Home
>
National Drug Code (NDC)
>
Protopam Chloride
Protopam Chloride - 60977-141-01 - (pralidoxime chloride)
Drug Information of Protopam Chloride
| Product NDC: | 60977-141 |
| Proprietary Name: | Protopam Chloride |
| Non Proprietary Name: | pralidoxime chloride |
| Active Ingredient(s): | 1 g/1 & nbsp; pralidoxime chloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Protopam Chloride
| Product NDC: | 60977-141 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA014134 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101206 |
Package Information of Protopam Chloride
| Package NDC: | 60977-141-01 |
| Package Description: | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (60977-141-27) |
NDC Information of Protopam Chloride
| NDC Code | 60977-141-01 |
| Proprietary Name | Protopam Chloride |
| Package Description | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (60977-141-27) |
| Product NDC | 60977-141 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pralidoxime chloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20101206 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | PRALIDOXIME CHLORIDE |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Cholinesterase Reactivator [EPC],Cholinesterase Reactivators [MoA] |
